However, despite the increased awareness of COIs by physicians, emphasis by academic medical centers for faculty physicians to report COIs, 24 regulation in the United
States with national disclosure of payments from industry to physicians and teaching hospitals (eg, Open Payments), 25 and tracking of payments to physicians by consumer groups (eg, Dollars for Docs), 26 problems with COI reporting by authors of articles published in biomedical journals persist. These problems include failure to disclose financial and other important potential COIs, as well as incomplete disclosures, inconsistent disclosures, and misinterpretation of what represents a relevant disclosure. The recent investigation of a prominent c ancer researcher for failure to disclose substantial financial and administrative relationships with drug and health care companies in leading medical journals and his subsequent resignation as chief medical officer of a leading cancer center has once again placed the issue of COI center stage. 27 Although failure to disclose COIs is not limited to the field of oncology, a recent study found that 32% of 344 oncologist authors did not fully disclose payments from the sponsors of clinical trials of oncology drugs published in major medical journals. 28 Other recent studies have documented incomplete COI disclosures among medical specialties, with inaccurate disclosures of industry relationships involving 22 (55%) of 40 authors of dermatology clinical practice guidelines, 29 and discrepancies between disclosure statements and publicly available data on payments from industry involving 3 (6%) of 49 authors of otolaryngology clinical practice guidelines. 30 Another study of the 100 physicians who received the highest compensation from large device manufacturers in 2015 revealed that of the 225 articles published in 2016 by these physicians and for which these payments were relevant, only 84 articles (37.3%) included self-declared COI information from the authors. 31 These recent reports follow the publication of numerous previous articles indicating that disclosure of COIs in medical journals is inadequate.
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Responsibilities of Authors answers "no" to 1 of 4 specific questions about potential COIs, a pop-up message appears asking if the author is certain that "no" is the correct answer. In addition, the pop-up message asks if the author's answer is consistent with disclosures in recently published articles. One of the recurring issues is inconsistency in an author's reporting of specific COIs. Often, when allegations of inadequate COI disclosures are made, it is because authors have reported inconsistent disclosures in related recent publications (eg, in different articles or in different journals). Sometimes these differences are appropriate (such as when different journals have different disclosure policies), but sometimes they are not, and some readers (often with their own conflicts) and investigative journalists have asked about such inconsistent reporting of disclosures. However, these new approaches, prompts, and reminders for reporting COI disclosures will not be effective if authors fail to completely report or misrepresent their COI information. Just as authors are expected to operate under the principles of honesty and integrity in reporting the results of research studies, authors also are expected to operate under these same principles with reporting of financial and other COI disclosures. Complete and detailed reporting of potential COIs is essential to maintain confidence and trust in biomedical research, and to ensure transparency with respect to understanding possible relationships between authors' potential COIs and the information reported in their articles. In addition to reporting complete and detailed financial COI information, authors are encouraged to report other information that may be relevant to the subject matter of their article. For instance, an author who serves or recently has served as an officer of a medical society or advocacy organization who writes about topics that have relevance for that organization also is expected to include that additional information in his or her COI disclosures.
Some have suggested that there should be a central database of all author COI disclosures and financial interests to which journals can link or that editors and readers could search to check for COIs of authors of submitted manuscripts and published articles. Such systems may be feasible and some are operating, 25,26,38 but they are based in the United States and may not work for authors outside of the United States, may contain incomplete or inaccurate information, and may be expensive and burdensome to manage and function effectively within the editorial evaluation and publication processes. In addition, such centralized systems might not address that relevant COIs may vary from article to article. Moreover, disassociating authors' disclosures with specific submitted manuscripts and published articles (even with linking to disclosures in an external database) could make real-time assessment more challenging for editors and peer reviewers, and ultimately for readers. In addition, it is not clear how these systems, or how reporting financial disclosure information on institutional sites, such as is required by some academic medical centers, can address intellectual COIs or other relevant disclosures that can influence an individual's interpretation of data. In addition, academic medical centers and other organizations have increased efforts to encourage 24 and promote transparent reporting of financial interests and other COI disclosures, such as by posting faculty COI information on institutional websites. Botkin 41 has suggested that institutional COI policies should be strengthened, such as by considering the intentional or negligent failure to disclose significant financial relationships relevant to the conduct of research to be a form of research reporting misconduct. Accordingly, the editors are considering a plan to notify the institution or organization responsible for oversight of the author who has a substantial undeclared or inaccurate COI disclosure in a published article by sending the institution the subsequently published Letter reporting the problematic disclosures. The editors are also considering, on a caseby-case basis, notifying the funding source or sponsor for the work reported in the article that involved undisclosed COI information. Institutions and funders could then decide whether further action is required. Additional steps may be necessary to help reduce the occurrence of undeclared, incomplete, or inconsistent reporting of COI information in published articles. If problems with reporting COI disclosures persist, especially if more high-profile cases occur, public trust in biomedical research and medical journals will be adversely affected, and government agencies and others may consider further regulatory action.
Box. International Committee of Medical Journal Editors (ICMJE) Definition and Terms for Conflict of Interest Disclosures
Any potential conflicts of interest "involving the work under consideration for publication" (during the time involving the work, from initial conception and planning to present), Any "relevant financial activities outside the submitted work" (over the 3 years prior to submission), and Any "other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing" what is written in the submitted work (based on all relationships that were present during the 3 years prior to submission). 
Responsibilities of Editors

Conclusions
COIs are likely to become more challenging in the years to come. As more investigators and their institutions have and enter into financial relationships from which they benefit, it is critical that authors report COI information accurately, completely, and transparently so readers can evaluate whether the information in the article could be biased because of authors' potential COIs. Equally as important, if not more important, are the responsibilities of editors to ensure that published information is accurate and objective and to maintain the integrity of the scientific record. Ultimately, physicians, other health care professionals, and other readers must assess the information available to them, determine the value and importance of an article, and make decisions about its applicability to clinical care and contribution to health.
ARTICLE INFORMATION
Author Affiliations: JAMA and the JAMA Network, Chicago, Illinois.
